Valneva SE
NASDAQ:VALNBiotechnology
+$0.01 today
- Market cap
- $507.98M
- Beta
- 1.40
- P/E (TTM)
- -2.9
- EPS (TTM)
- -$0.80
Volume 0.00M
Average 0.09M
VALN Revenue
Total income from selling goods and services before any costs are deducted; the top line of the income statement.
Valneva SENASDAQ: VALN
Revenue · Q1 FY2026 · quarter ended Mar 2026
Revenue declines year over year
Q1 FY2026 revenue of €30.9M fell 37.2% year over year, behind the -16.0% change in trailing-twelve-month revenue. Sequentially, it fell 35.2% from the prior quarter. Over 3 fiscal years it compounded at -21.5% a year.
Context
- Revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether revenue reaches the consensus estimate from 5 analysts of €154.45M (-11.6%) for the fiscal year ending Dec 2026, a slowdown from the +3.0% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- €30.9M-35.2% QoQ
- Last fiscal yearDec 2025
- €174.66M+3.0% YoY
- LTMMar 2026
- €156.33M-16.0% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | -37.2% | -12.8% | +24.4 pp |
| 1 year | +3.0% | -11.6% | -14.6 pp |
| 3-year CAGR | -21.5% | +12.7% | +34.3 pp |
| 5-year CAGR | +19.7% | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Revenue history
EUR · from the income statement
- Latest · FY2025
- 174.66M EUR
- Year-over-year change
- +3.0%
- 4-year CAGR
- -15.8%
| Period | Period end | Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 174.66M | +3.0% |
| FY2024 | 2024-12-31 | 169.58M | +10.3% |
| FY2023 | 2023-12-31 | 153.71M | -57.5% |
| FY2022 | 2022-12-31 | 361.3M | +3.8% |
| FY2021 | 2021-12-31 | 348.09M | — |
Revenue vs competitors
How VALN compares with its peers on the latest reported figures
- Peers report in different currencies, so revenue is compared through growth and rates rather than absolute size.
- Its year-over-year change of -16.0% is the 4th highest of 7, against a peer median of -19.4%.
- Over three fiscal years its annual growth of -21.5% compares with a peer median of -42.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Sep 2026 | $2.53B USD | +13.7% | -53.1% | |
| LTM Mar 2026 | $596.34M USD | -52.5% | -11.1% | |
| LTM Sep 2026 | $182.57M USD | +121.2% | +678.6% | |
| LTM Mar 2026 | €156.33M EUR | -16.0% | -21.5% | |
| LTM Mar 2026 | $65.5M USD | +214.0% | -65.1% | |
| LTM Mar 2026 | $45.35M USD | -66.4% | -31.1% | |
| LTM Jun 2026 | $0 USD | — | — | |
| LTM Mar 2026 | $0 USD | -100.0% | -81.5% | |
| Peer median (excluding VALN) | — | -19.4% | -42.1% | |
Competitors are the stored peer set for VALN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 348.09M | 361.3M | 153.71M | 169.58M | 174.66M |
| Cost of Revenue | 187.92M | 324.44M | 100.88M | 98.54M | 107.14M |
| Gross Profit | 160.17M | 36.86M | 52.84M | 71.04M | 67.52M |
| Gross Margin | 46.0% | 10.2% | 34.4% | 41.9% | 38.7% |
| Research & Development | 173.28M | 104.92M | 59.89M | 74.14M | 85.3M |
| Selling, General & Admin | 71.25M | 57.58M | 96.55M | 95.11M | 74.68M |
| Operating Expenses | 221.56M | 150.31M | 134.92M | 57.71M | 149.15M |
| Depreciation & Amortization | 14.28M | 21.04M | 17.58M | 19.59M | 21.75M |
| EBITDA | (38.74M) | (104.73M) | (57.72M) | 32.08M | (50.47M) |
| EBITDA Margin | -11.1% | -29.0% | -37.6% | 18.9% | -28.9% |
| Operating Income | (61.39M) | (113.44M) | (82.09M) | 13.33M | (81.63M) |
| Operating Margin | -17.6% | -31.4% | -53.4% | 7.9% | -46.7% |
| Interest Income | 249K | 260K | 1.21M | 2.36M | 1.8M |
| Interest Expense | 16.96M | 19.05M | 23.33M | 23.98M | 41.9M |
| Other Income / Expenses | (8.59M) | (31.37M) | (16.54M) | (24.82M) | (32.49M) |
| Income Before Tax | (69.98M) | (144.82M) | (98.63M) | (11.49M) | (114.12M) |
| Pre-Tax Margin | -20.1% | -40.1% | -64.2% | -6.8% | -65.3% |
| Income Tax Expense | 3.45M | (1.54M) | 2.8M | 761K | 1.07M |
| Net Income | (73.43M) | (143.28M) | (101.43M) | (12.25M) | (115.19M) |
| Net Margin | -21.1% | -39.7% | -66.0% | -7.2% | -66.0% |
| EPS (Basic) | (1.50) | (2.48) | (1.46) | (0.17) | (1.32) |
| EPS (Diluted) | (1.50) | (2.48) | (1.46) | (0.17) | (1.32) |
| Weighted Avg Shares | 48.81M | 57.74M | 69.47M | 70.26M | 84.09M |
| Weighted Avg Shares (Diluted) | 48.81M | 57.74M | 69.31M | 70.26M | 84.09M |
Valneva SE
NASDAQ:VALN
Intrinsic Alpha fair value
Locked
Current Price
$5.34
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.